| NCT ID | NCT04906356 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cardiology Research UBC |
| Condition | Spontaneous Coronary Artery Dissection |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2018-12-01 |
| Primary Completion | 2033-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2018-12-01 with a primary completion date of 2033-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Natural history multicenter, prospective, observational registry with 10-year follow-up
Eligibility Criteria
Inclusion Criteria: 1. Patients admitted with ACS (STEMI, NSTEMI or unstable angina) 2. Documented SCAD on a coronary angiogram (including diagnosis with OCT or IVUS) Exclusion Criteria: 1\. Patients where SCAD is attributed to atherosclerotic coronary artery disease, with atherosclerotic coronary artery disease stenosis ≥50%
Contact & Investigator
Jacqueline Saw, MD
PRINCIPAL INVESTIGATOR
Cardiology Research UBC / Vancouver General Hospital
Frequently Asked Questions
Who can join the NCT04906356 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spontaneous Coronary Artery Dissection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04906356 currently recruiting?
Yes, NCT04906356 is actively recruiting participants. Contact the research team at a.starovoytov@ubc.ca for enrollment information.
Where is the NCT04906356 trial being conducted?
This trial is being conducted at Vancouver, Canada.
Who is sponsoring the NCT04906356 clinical trial?
NCT04906356 is sponsored by Cardiology Research UBC. The principal investigator is Jacqueline Saw, MD at Cardiology Research UBC / Vancouver General Hospital. The trial plans to enroll 3,000 participants.